145 related articles for article (PubMed ID: 26366802)
1. Pharmacogenetic tests to predict the efficacy of aspirin desensitization in patients with aspirin-exacerbated respiratory diseases; HLA-DQB302.
Esmaeilzadeh H; Nabavi M; Aryan Z; Amirzargar AA
Expert Rev Respir Med; 2015 Oct; 9(5):511-8. PubMed ID: 26366802
[TBL] [Abstract][Full Text] [Related]
2. HLA-DRB and HLA-DQ genetic variability in patients with aspirin-exacerbated respiratory disease.
Esmaeilzadeh H; Nabavi M; Amirzargar AA; Aryan Z; Arshi S; Bemanian MH; Fallahpour M; Mortazavi N; Rezaei N
Am J Rhinol Allergy; 2015; 29(3):e63-9. PubMed ID: 25975240
[TBL] [Abstract][Full Text] [Related]
3. Aspirin desensitization for patients with aspirin-exacerbated respiratory disease: A randomized double-blind placebo-controlled trial.
Esmaeilzadeh H; Nabavi M; Aryan Z; Arshi S; Bemanian MH; Fallahpour M; Mortazavi N
Clin Immunol; 2015 Oct; 160(2):349-57. PubMed ID: 26083948
[TBL] [Abstract][Full Text] [Related]
4. Meta-analysis Exploring Sinopulmonary Outcomes of Aspirin Desensitization in Aspirin-Exacerbated Respiratory Disease.
Chaaban MR; Moffatt D; Wright AE; Cowthran JA; Hsu ES; Kuo YF
Otolaryngol Head Neck Surg; 2021 Jan; 164(1):11-18. PubMed ID: 32571140
[TBL] [Abstract][Full Text] [Related]
5. The effect of aspirin desensitization on novel biomarkers in aspirin-exacerbated respiratory diseases.
Katial RK; Strand M; Prasertsuntarasai T; Leung R; Zheng W; Alam R
J Allergy Clin Immunol; 2010 Oct; 126(4):738-44. PubMed ID: 20728206
[TBL] [Abstract][Full Text] [Related]
6. Failure of tacrolimus to prevent aspirin-induced respiratory reactions in patients with aspirin-exacerbated respiratory disease.
Stevenson DD; Mehra PK; White AA; Gupta S; Woessner KM; Simon RA
J Allergy Clin Immunol; 2005 Oct; 116(4):755-60. PubMed ID: 16210047
[TBL] [Abstract][Full Text] [Related]
7. The clinical dilemma of "silent desensitization" in aspirin-exacerbated respiratory disease.
White AA; Bosso JV; Stevenson DD
Allergy Asthma Proc; 2013; 34(4):378-382. PubMed ID: 23883603
[TBL] [Abstract][Full Text] [Related]
8. Treatment of aspirin exacerbated respiratory disease with a low salicylate diet: a pilot crossover study.
Sommer DD; Hoffbauer S; Au M; Sowerby LJ; Gupta MK; Nayan S
Otolaryngol Head Neck Surg; 2015 Jan; 152(1):42-7. PubMed ID: 25344589
[TBL] [Abstract][Full Text] [Related]
9. HLA-DQA1, DQB1 and DRB1 alleles associated with Takayasu arteritis in the Chinese Han population.
Lv N; Wang Z; Dang A; Zhu X; Liu Y; Zheng D; Liu G
Hum Immunol; 2015 Apr; 76(4):241-4. PubMed ID: 25636572
[TBL] [Abstract][Full Text] [Related]
10. Effect of misoprostol on patients with aspirin-exacerbated respiratory disease undergoing aspirin challenge and desensitization.
Walters KM; Simon RA; Woessner KM; Wineinger NE; White AA
Ann Allergy Asthma Immunol; 2017 Jul; 119(1):71-76. PubMed ID: 28668243
[TBL] [Abstract][Full Text] [Related]
11. An economic analysis of aspirin desensitization in aspirin-exacerbated respiratory disease.
Shaker M; Lobb A; Jenkins P; O'Rourke D; Takemoto SK; Sheth S; Burroughs T; Dykewicz MS
J Allergy Clin Immunol; 2008 Jan; 121(1):81-7. PubMed ID: 17716716
[TBL] [Abstract][Full Text] [Related]
12. Safety and outcomes of aspirin desensitization for aspirin-exacerbated respiratory disease: A single-center study.
Waldram J; Walters K; Simon R; Woessner K; Waalen J; White A
J Allergy Clin Immunol; 2018 Jan; 141(1):250-256. PubMed ID: 28550988
[TBL] [Abstract][Full Text] [Related]
13. The blocking effect of essential controller medications during aspirin challenges in patients with aspirin-exacerbated respiratory disease.
White AA; Stevenson DD; Simon RA
Ann Allergy Asthma Immunol; 2005 Oct; 95(4):330-5. PubMed ID: 16279562
[TBL] [Abstract][Full Text] [Related]
14. The human leucocyte antigen-DRB1*1302-DQB1*0609-DPB1*0201 haplotype may be a strong genetic marker for aspirin-induced urticaria.
Kim SH; Choi JH; Lee KW; Kim SH; Shin ES; Oh HB; Suh CH; Nahm DH; Park HS
Clin Exp Allergy; 2005 Mar; 35(3):339-44. PubMed ID: 15784113
[TBL] [Abstract][Full Text] [Related]
15. Long-term sinonasal outcomes of aspirin desensitization in aspirin exacerbated respiratory disease.
Cho KS; Soudry E; Psaltis AJ; Nadeau KC; McGhee SA; Nayak JV; Hwang PH
Otolaryngol Head Neck Surg; 2014 Oct; 151(4):575-81. PubMed ID: 25118195
[TBL] [Abstract][Full Text] [Related]
16. Performing Aspirin Desensitization in Aspirin-Exacerbated Respiratory Disease.
Waldram JD; Simon RA
Immunol Allergy Clin North Am; 2016 Nov; 36(4):693-703. PubMed ID: 27712764
[TBL] [Abstract][Full Text] [Related]
17. An Hourly Dose-Escalation Desensitization Protocol for Aspirin-Exacerbated Respiratory Disease.
Chen JR; Buchmiller BL; Khan DA
J Allergy Clin Immunol Pract; 2015; 3(6):926-31.e1. PubMed ID: 26282158
[TBL] [Abstract][Full Text] [Related]
18. HLA-DQ A1, -DQB1 and -DRB1 gene polymorphism--in Malay type 1 diabetes mellitus patients and their use for risk prediction.
Rohana AG; Loh KC; Tin SK; Soh CH; Nazaimoon WM; Fong KY; Azmi KN; Khalid BA
Med J Malaysia; 2011 Jun; 66(2):133-7. PubMed ID: 22106694
[TBL] [Abstract][Full Text] [Related]
19. Association of HLA class II alleles with hepatitis C virus clearance and persistence in thalassemia patients from Iran.
Samimi-Rad K; Sadeghi F; Amirzargar A; Eshraghian MR; Alavian SM; Rahimnia R
J Med Virol; 2015 Sep; 87(9):1565-72. PubMed ID: 25970464
[TBL] [Abstract][Full Text] [Related]
20. Frequency and severity of reactions to a 325-mg aspirin dose during desensitization.
Schuler CF; Baldwin JL; Baptist AP
Ann Allergy Asthma Immunol; 2017 Mar; 118(3):333-338.e1. PubMed ID: 28065801
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
